Oral fucose ameliorated DSS-induced colitis by lowering taurine-β-MCA (an FXR antagonist) and TCA, restoring the FXR-FGF15-CYP7A1 pathway, and increasing Lactobacillus. This evidence concerns the gene CYP7A1 and colitis.